Daclatasvir/asunaprevir based direct-acting antiviral therapy ameliorate hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis: a case report

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
1471-2369
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Daclatasvir/asunaprevir based direct-acting antiviral therapy ameliorate hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis: a case report ; volume:18 ; number:1 ; day:29 ; month:3 ; year:2017 ; pages:1-4 ; date:12.2017
BMC nephrology ; 18, Heft 1 (29.3.2017), 1-4, 12.2017

Urheber
Shimada, Michiko
Beteiligte Personen und Organisationen
Nakamura, Norio
Endo, Tetsu
Yamabe, Hideaki
Nakamura, Masayuki
Murakami, Reiichi
Narita, Ikuyo
Tomita, Hirofumi
SpringerLink (Online service)

DOI
10.1186/s12882-017-0534-5
URN
urn:nbn:de:1111-2017041616405
Rechteinformation
Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:24 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Shimada, Michiko
  • Nakamura, Norio
  • Endo, Tetsu
  • Yamabe, Hideaki
  • Nakamura, Masayuki
  • Murakami, Reiichi
  • Narita, Ikuyo
  • Tomita, Hirofumi
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Role of different direct-acting antiviral drugs on hepatitis C virus-associated mixed cryoglobulinemia in Egyptian patients

Role of different direct-acting antiviral drugs on hepatitis C virus-associated mixed cryoglobulinemia in Egyptian patients

Successful Treatment of Oral Lichen Planus with Direct-Acting Antiviral Agents after Liver Transplantation for Hepatitis C Virus-Associated Hepatocellular Carcinoma

Successful Treatment of Oral Lichen Planus with Direct-Acting Antiviral Agents after Liver Transplantation for Hepatitis C Virus-Associated Hepatocellular Carcinoma

Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use

Direct-Acting Antiviral Therapy for Hepatitis C: Attitudes Regarding Future Use

Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era

Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era

Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis

Direct-acting antiviral resistance of Hepatitis C virus is promoted by epistasis

Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study

Adoption of direct-acting antiviral medications for hepatitis C: a retrospective observational study

Varicella Zoster Virus-Associated Meningitis as a Rebound Varicella Zoster Disease after Antiviral Discontinuation

Varicella Zoster Virus-Associated Meningitis as a Rebound Varicella Zoster Disease after Antiviral Discontinuation

HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)

HCV and kidney transplant in the era of new direct-acting antiviral agents (DAAs)

Acute reversible rhabdomyolysis during direct-acting antiviral hepatitis C virus treatment: a case report

Acute reversible rhabdomyolysis during direct-acting antiviral hepatitis C virus treatment: a case report

Clinicopathologic features and long-term prognosis of hepatitis B virus-associated glomerulonephritis: a retrospective cohort study

Clinicopathologic features and long-term prognosis of hepatitis B virus-associated glomerulonephritis: a retrospective cohort study

Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination

Modeling HIV-HCV coinfection epidemiology in the direct-acting antiviral era: the road to elimination

Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C

Direct-acting antiviral treatment downregulates immune checkpoint inhibitor expression in patients with chronic hepatitis C

Verbundene Objekte